- Info
- Insider Trading
- Financials
- Holders: TIL, TIL
Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL)
CUSIP: 45783C200
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common stock, par value $ 0.000001 per share
- Shares outstanding
- 6,505,400
- Total 13F shares
- 2,751,266
- Share change
- -596,529
- Total reported value
- $57,311,087
- Price per share
- $20.83
- Number of holders
- 37
- Value change
- -$11,020,093
- Number of buys
- 16
- Number of sells
- 24
Quarterly Holders Quick Answers
What is CUSIP 45783C200?
CUSIP 45783C200 identifies TIL - Instil Bio, Inc. - Common stock, par value $ 0.000001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45783C200:
Top shareholders of TIL - Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Curative Ventures V LLC |
13F
|
Company |
28%
|
1,899,004
|
$32,966,709 | — | 31 Mar 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
9%
|
585,485
|
$10,164,020 | — | 31 Mar 2025 | |
| BML Capital Management, LLC |
13F
|
Company |
6.4%
|
416,720
|
$7,234,259 | — | 31 Mar 2025 | |
| Vivo Capital IX, LLC |
13D/G
|
— |
4.5%
|
292,743
|
$7,169,276 | $0 | 30 Jun 2025 | |
| CPMG Inc |
13F
|
Company |
6.3%
|
410,922
|
$7,133,606 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
4.9%
|
317,324
|
$5,508,745 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.3%
|
212,244
|
$3,684,556 | — | 31 Mar 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
3.1%
|
203,933
|
$3,540,277 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.6%
|
168,098
|
$2,918,181 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2%
|
132,431
|
$2,299,002 | — | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.8%
|
116,785
|
$2,027,388 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.6%
|
104,943
|
$1,821,810 | — | 31 Mar 2025 | |
| Boxer Capital Management, LLC |
13F
|
Company |
1.2%
|
80,125
|
$1,390,970 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
77,349
|
$1,343,108 | — | 31 Mar 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
1.1%
|
69,000
|
$1,197,840 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.89%
|
57,971
|
$1,006,376 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.82%
|
53,097
|
$921,764 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.66%
|
43,215
|
$750,554 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.61%
|
40,000
|
$694,400 | — | 31 Mar 2025 | |
| VR Adviser, LLC |
13F
|
Company |
0.51%
|
33,177
|
$575,953 | — | 31 Mar 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.48%
|
31,314
|
$543,611 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.37%
|
24,328
|
$422,334 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.34%
|
22,298
|
$387,093 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.3%
|
19,351
|
$335,933 | — | 31 Mar 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.29%
|
18,700
|
$324,632 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.27%
|
17,595
|
$305,449 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.27%
|
17,280
|
$299,981 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.23%
|
14,826
|
$257,379 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.21%
|
13,864
|
$240,679 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.21%
|
13,490
|
$233,000 | — | 31 Mar 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.17%
|
11,165
|
$193,824 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.16%
|
10,511
|
$182,471 | — | 31 Mar 2025 | |
| AlphaQuest LLC |
13F
|
Company |
0.08%
|
5,397
|
$93,692 | — | 31 Mar 2025 | |
| Pinpoint Asset Management Ltd |
13F
|
Company |
0.08%
|
5,094
|
$88,432 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.05%
|
3,232
|
$56,108 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
1,392
|
$24,165 | — | 31 Mar 2025 | |
| Na Bokf |
13F
|
Individual |
0.01%
|
454
|
$7,881 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
114
|
$1,979 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
79
|
$1,367 | — | 31 Mar 2025 | |
| Lindbrook Capital, LLC |
13F
|
Company |
0%
|
68
|
$1,180 | — | 31 Mar 2025 | |
| EQ WEALTH ADVISORS, LLC |
13F
|
Company |
0%
|
40
|
$694 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
34
|
$590 | — | 31 Mar 2025 | |
| Frazier Financial Advisors, LLC |
13F
|
Company |
0%
|
15
|
$261 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
2
|
$35 | — | 31 Mar 2025 | |
| Timothy L. Moore |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
750,000
|
— | — | 06 Sep 2022 | |
| Zachary Roberts |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
245,000
|
— | — | 04 Mar 2022 | |
| Vijay Chiruvolu |
3/4/5
|
Chief Technical Officer |
—
class O/S missing
|
154,237
|
— | — | 20 May 2022 | |
| Bronson Crouch |
3/4/5
|
CEO and Chairman, Director, 10%+ Owner |
—
class O/S missing
|
105,157
|
— | — | 25 Apr 2025 | |
| Sumita Ray |
3/4/5
|
Chief Legal and Admin Officer |
—
class O/S missing
|
50,000
|
— | — | 08 Jan 2023 | |
| George Matcham |
3/4/5
|
Director |
—
class O/S missing
|
6,500
|
— | — | 28 May 2025 |
Institutional Holders of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) as of Q2 2025
As of 30 Jun 2025,
Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,751,266 shares.
The largest 10 holders included
BML Capital Management, LLC, CPMG Inc, Vivo Capital, LLC, Siren, L.L.C., VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, Balyasny Asset Management L.P., and SECTORAL ASSET MANAGEMENT INC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
42
Q2 2025 holders
37
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.